Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Biology|November 11, 2022
Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis PatientsMaría Inmaculada Domínguez-Mozo, María Celeste García-Frontini Nieto, María Isabel Gómez-Calcerrada, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 10, 2017
Metabolomic signatures associated with disease severity in multiple sclerosisPablo Villoslada, Cristina Alonso, Ion Agirrezabal, et al.European Journal of Clinical Investigation|December 31, 2016
Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohortMaría I Dominguez-Mozo, Macarena Rus, Jose L Santiago, et al.Frontiers in Immunology|June 24, 2024
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progressionMaria Inmaculada Dominguez-Mozo, Victoria Galán, Lluís Ramió-Torrentà, et al.Journal of Neurology|October 14, 2017
Blood lymphocyte subsets identify optimal responders to IFN-beta in MSRaquel Alenda, Lucienne Costa-Frossard, Roberto Alvarez-Lafuente, et al.Journal of Neurology|November 28, 2017
Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MSRaquel Alenda, Lucienne Costa-Frossard, Roberto Alvarez-Lafuente, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosisJose E Martínez-Rodríguez, Alvaro Cobo-Calvo, Luisa M Villar, et al.Annals of the Rheumatic Diseases|May 26, 2010
Large-scale gene expression in bone marrow mesenchymal stem cells: a putative role for COL10A1 in osteoarthritisJosé Ramón Lamas, Luis Rodríguez-Rodríguez, Ana G Vigo, et al.Journal of the Neurological Sciences|October 4, 2011
Herpesvirus active replication in multiple sclerosis: a genetic control?Marta Garcia-Montojo, Alfonso Martinez, Virginia De Las Heras, et al.Frontiers in Immunology|January 3, 2022
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta TreatmentPablo Aliaga-Gaspar, Isaac Hurtado-Guerrero, Nicolas Lundahl Ciano-Petersen, et al.Pageof 6